The Food and Drug Administration has reduced an obstacle from its compassionate-use policy, streamlining paperwork that physicians must submit to obtain experimental drugs for patients with life-threatening illnesses.
![](https://www.georgiahealthnews.com/wp-content/uploads/sites/6/2010/11/Photoxpress_2482852-e1465414318143.jpg?w=300)
The Food and Drug Administration has reduced an obstacle from its compassionate-use policy, streamlining paperwork that physicians must submit to obtain experimental drugs for patients with life-threatening illnesses.